期刊文献+

氟比洛芬酯微乳注射液大鼠组织分布及靶向性研究 被引量:5

Study on distribution in rats and targeting property of flurbiprofen axetil microemulsion
下载PDF
导出
摘要 目的:研究自制的氟比洛芬酯(FA)微乳注射液在大鼠体内的组织分布并评价其在手术切口创伤炎症部位靶向性。方法:建立大鼠手术切口创伤模型,随机分成2组,分别经尾静脉注射氟比洛芬酯微乳和氟比洛芬溶液注射液,在给药后15,30,60,120,240 min处死大鼠,取血清、心、肝、脾、肺、肾、创伤肌肉组织及正常肌肉组织,HPLC法测定样本氟比洛芬浓度。结果:微乳注射液组在体内血液及各组织脏器消除速度较溶液组慢,5个时间点氟比洛芬酯微乳注射液组手术侧创伤肌肉组织中药物浓度均高于非手术侧正常肌肉组织(P<0.05),而溶液注射液组差异无统计学意义(P>0.05)。微乳组药物创伤肌肉组织靶向效率Te=12.21%,而溶液组Te=3.97%,微乳注射液对普通溶液注射液创伤肌肉组织相对摄取率Re=4.15。结论:氟比洛芬酯微乳注射液静脉注射后在大鼠手术切口创伤炎症部位有靶向性,具有靶向消炎镇痛的作用。 Objective: To study the distribution of flurbiprofen axetil (FA) microomulsion in rats and evaluate the targeting property to traumatic inflammation tissue. Methods: Traumatic injury model rats were established by hip surgery on the rat right thigh muscle and randomly divided into 2 groups : microemulsion group and solution group. Serums and tissues of rats were collected at 15, 30, 60, 120 and 240min after administration (iv. 5 mg· kg^-1). A high performance liquid chromatography (HPLC) with UV detection was developed to study the concentration of flurbiprofen in biological samples. Results: The elimination of flurbiprofen axetil microemulsion from blood and tissues was slower than flurbiprofen solution. At each 5 time points, drug concentrations of microemulsion group in injury muscle were higher than in normal muscle (P 〈 0.05 ), while solution group had no significant difference( P 〉 0.05 ). Microemulsion group injury muscle T~ (targeting efficiency) = 12.21%, and the solution group Te = 3.97%. The Re (relative uptake rate) of injury muscle was 4.15. Conclusion: The flurbiprofen axetil microemulsion has the targeting property to traumatic injury tissues.
出处 《中国药师》 CAS 2015年第6期932-935,977,共5页 China Pharmacist
关键词 氟比洛芬 组织分布 靶向 镇痛 Flurbiprofen Tissue distribution Targeting Analgesia
  • 相关文献

参考文献11

  • 1付志强,吕国义,邓廼封.氟比洛芬酯的药理及临床应用[J].中日友好医院学报,2007,21(3):178-180. 被引量:18
  • 2Hua S,Cabot PJ. Targeted Nanoparticles that Mimic Immune Cells inPain Control Inducing Analgesic and Anti -inflammatory Actions : APotential Novel Treatment of Acute and Chronic Pain Conditions[ J].Pain Physician t20\3f 16: 199-216.
  • 3Brennan TJ, Vandenneulen EP,Gebhart GF. Characterization of a ratmodel of incisional pain[ J], Pain, 1996,64:493-501.
  • 4丁雪鹰,王世岭,张沂,高申.反相高效液相色谱法测定人体内氟比洛芬含量[J].中国医院药学杂志,2001,21(8):472-473. 被引量:10
  • 5李娟.高效液相色谱法测定酮洛芬肠溶胶囊和搽剂的含量[J].中国医院药学杂志,2010,30(9):798-800. 被引量:3
  • 6Park KM^Lee MK,Hwang KJ. Phospholipid-based microemulsions offlurbiprofen by the spontaneous emubiilcation process [ J]. Interna-tional Journal of Pharmaceutics, 1999,183: 145-154.
  • 7Tokumura T, Muraoka A f Machida Y. Improvement of oral bioavail-ability of flurbiprofen from flurijiprofen/b-cyclodextrininclusion com-plex by action of cinnarizine[ J] . European Journal of Pharmaceuticsand Biopharmaceutics ,2009,73 : 202-204.
  • 8Ye J,Wang Q,Zhou X. Injectable actarit-loaded solid lipid nanoparti-cles as passive tai^eting therapeutic agents for riieumatoid arthritis[J ]. International Journal of Pharmaceutics,2008,352 (1 -2) : 273 -279.
  • 9Wu Z, Alany RG, Tawfeek N. A study of microemulsions as pro-longed-release injectables through in-situ phase transition[ J]. J Con-trol fleW,2014,174:188-194.
  • 10段砺瑕,李晓玲.氟比洛芬酯注射液的药理作用及临床应用[J].中国新药杂志,2004,13(9):851-852. 被引量:601

二级参考文献39

共引文献626

同被引文献53

引证文献5

二级引证文献56

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部